Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-Beta as a Master Regulator of Diabetic Nephropathy
Li Wang, Honglian Wang, Tong‐Tong Liu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7881-7881
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Na Wang, Chun Zhang
Antioxidants (2024) Vol. 13, Iss. 4, pp. 455-455
Open Access | Times Cited: 39
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
Na Wang, Chun Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3086-3086
Open Access | Times Cited: 23
Human bone marrow mesenchymal stem cell-derived extracellular vesicles inhibit shoulder stiffness via let-7a/Tgfbr1 axis
Zhiwen Luo, Yaying Sun, Beijie Qi, et al.
Bioactive Materials (2022) Vol. 17, pp. 344-359
Open Access | Times Cited: 65
What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
Kimio Watanabe, Emiko Sato, Eikan Mishima, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 570-570
Open Access | Times Cited: 49
Role of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes
Honglian Wang, Li Wang, Chang-Ying Zhao, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 373-373
Open Access | Times Cited: 44
Involvement of Inflammasome Components in Kidney Disease
Ana Karina Aranda‐Rivera, Anjali Srivastava, Alfredo Cruz‐Gregorio, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 246-246
Open Access | Times Cited: 40
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease
Adriana Petrazzuolo, Gianmarco Sabiu, Emma Assi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106710-106710
Open Access | Times Cited: 29
Pathomechanisms of Diabetic Kidney Disease
Satyesh K. Sinha, Susanne B. Nicholas
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7349-7349
Open Access | Times Cited: 23
Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets
Allison B. Reiss, Berlin Jacob, Aarij Zubair, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1881-1881
Open Access | Times Cited: 13
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3969-3969
Open Access | Times Cited: 13
ADAMTS13 attenuates renal fibrosis by suppressing thrombospondin 1 mediated TGF-β1/Smad3 activation
Jie Guo, Suhan Zhou, Honghong Wang, et al.
Toxicology and Applied Pharmacology (2025) Vol. 496, pp. 117260-117260
Closed Access | Times Cited: 1
Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 2
Aleksey M. Chaulin
Life (2021) Vol. 11, Iss. 11, pp. 1175-1175
Open Access | Times Cited: 42
Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway
Ting-feng Zou, Zhigang Liu, Peichang Cao, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 10, pp. 2065-2074
Closed Access | Times Cited: 21
Biochanin A Ameliorates Nephropathy in High-Fat Diet/Streptozotocin-Induced Diabetic Rats: Effects on NF-kB/NLRP3 Axis, Pyroptosis, and Fibrosis
Chetan Ram, Shobhit Gairola, Shobhit Verma, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1052-1052
Open Access | Times Cited: 17
Hyperglycemia modulates M1/M2 macrophage polarization in chronic diabetic patients with pulmonary tuberculosis infection
Sudhasini Panda, Alisha Arora, Kalpana Luthra, et al.
Immunobiology (2024) Vol. 229, Iss. 2, pp. 152787-152787
Open Access | Times Cited: 7
Shenfu injection: a review of pharmacological effects on cardiovascular diseases
Feifei Xu, Xiaofang Xie, HU Hai-yan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4‐mediated tubular ferroptosis
Jianchun Li, Jieke Yang, Qianwen Xian, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2656-2668
Closed Access | Times Cited: 7
A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications
Caiyan Qu, Xiyue Tan, Qichao Hu, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26863-e26863
Open Access | Times Cited: 6
Green tea peptides ameliorate diabetic nephropathy by inhibiting the TGF-β/Smad signaling pathway in mice
Xuhui Chen, Lingli Sun, Dongli Li, et al.
Food & Function (2022) Vol. 13, Iss. 6, pp. 3258-3270
Closed Access | Times Cited: 27
Luteolin improves nephropathy in hyperglycemic rats through anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms
Li‐You Chen, Hsinlin T. Cheng, Chih-Kai Liao, et al.
Journal of Functional Foods (2023) Vol. 102, pp. 105461-105461
Open Access | Times Cited: 13
Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7
Minmin Gong, Yujin Guo, Hui Dong, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115747-115747
Open Access | Times Cited: 13
Osthole ameliorates early diabetic kidney damage by suppressing oxidative stress, inflammation and inhibiting TGF-β1/Smads signaling pathway
Qiangsheng Li, Yifei Wang, Yan Jia, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112131-112131
Closed Access | Times Cited: 5
Corporate genome screening India (CoGsI) identified genetic variants association with T2D in young Indian professionals
Shah Fahad Husami, Tarundeep Kaur, Love Gupta, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ectodysplasin A/Ectodysplasin A Receptor System and Their Roles in Multiple Diseases
Zhensheng Cai, Xia Deng, Jue Jia, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 29
Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy
Hala M.F. Mohammad, Sahar Galal Gouda, Mohamed Ahmed Eladl, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114128-114128
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top